How hepatitis D virus can hinder the control of hepatitis B virus

PLoS ONE

Volumn 4, Issue 4, 2009, Pages

  Xiridou, Maria ^a   Borkent Raven, Barbara ^a,c   Hulshof, Joost ^b   Wallinga, Jacco ^a,c  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BASIC REPRODUCTION NUMBER; DEFECTIVE VIRUS; DELTA AGENT HEPATITIS; DISEASE SEVERITY; DISEASE SURVEILLANCE; ENDEMIC DISEASE; EPIDEMIC; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HUMAN; INFECTION CONTROL; MATHEMATICAL MODEL; MIXED INFECTION; PREVALENCE; SUPERINFECTION; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS TRANSMISSION; DISEASE TRANSMISSION; PHYSIOLOGY; THEORETICAL MODEL;

HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS;

HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS D; HEPATITIS DELTA VIRUS; MODELS, THEORETICAL;

EID: 65449148637     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005247     Document Type: Article

References (34)

1. Sureau C, Guerra B, Lanford R (1993) Role of the large hepatitis B virus envelope protein in infectivity of the hepatitis delta virion. J Virol 67: 366-72.
2. WHO (2001) Hepatitis Delta. Available at: http://www.who.int/csr/disease/ hepatitis/HepatitisD-whocdscsrncs2001-1.pdf. Accessed 2008 June 4.
3. Polish L, Gallagher M, Fields H, Hadler S (1993) Delta hepatitis: molecular biology and clinical and epidemiological features. Clin Microb Rev 6: 211-29.
4. Jardi R, Rodriguez F, Buti M, Costa X, Cotrina M, et al. (2001) Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology 34: 404-10.
5. Inoue J, Takahashi M, Nishizawa T, Narantuya L, Sakuma M, et al. (2005) High prevalence of hepatitis Delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia. J Med Virol 76: 333-340.
6. Kao J, Chen P, Lai M, Chen D (2002) Hepatitis D virus genotypes in intravenous drug users in Taiwan: decreasing prevalence and lack of correlation with hepatitis B virus genotypes. J Clin Microb 40: 3047-3049.
7. Gaeta G, Stroffolini T, Chiaramonte M, Ascione T, Stornaiuolo G, et al. (2002) Chronic hepatitis D: a vanishing disease? An italian multicenter study. Hepatology 32: 824-827.
8. Martcheva M, Pilyugin S, Holt R (2007) Subthreshold and superthreshold coexistence of pathogen variants: the impact of host age-structure. Math Biosci 207: 58-77.
9. Niro G, Rosina F, Rizzeto M (2005) Treatment of hepatitis D. J Viral Hepat 12: 2-9.
10. May R, Nowak M (1994) Superinfection, metapopulation dynamics, and the evolution of diversity. J Theor Biol 170: 95-114.
11. May R, Nowak M (1995) Coinfection and the evolution of parasite virulence. Proc R Soc London B 261: 209-215.
12. Ferguson N, Anderson R, Gupta S (1999) The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple strain pathogens. Proc Natl Acad Sci USA 96: 790-794.
13. Lloyd-Smith J, Poss M, Grenfell B (2008) HIV-1/parasite co-infection and the emergence of new parasite strains. Parasitology 135: 795-806.
14. Abu-Raddad L, Patnaik P, Kublin J (2006) Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. Science 314: 1603-1606.
15. Currie C, Williams B, Cheng R, Dye C (2003) Tuberculosis epidemics driven by HIV: is prevention better than cure? AIDS 17: 2501-2508.
16. Corbett E, Watt C, Walker N, Maher D, Williams B, Raviglione M, Dye C (2003) The growing burden of tuberculosis. Global trends and interactions with the HIV epidemic. Arch Intern Med 163: 1009-1021.
17. Williams B, Granich R, Chauhan L, Dharmshaktu N, Dye C (2005) The impact of HIV/AIDS on the control of tuberculosis in India. PNAS 102: 9619-9624.
18. Myers M, Laughlin C, Jay F, Carter B (1980) Adenovirus helper function for growth of adeno-associated virus: effect of temperature-sensitive mutations in adenovirus early gene region 2. J Virol 35: 65-75.
19. Nåsell I (2002) Stochastic models of some endemic infections. Math Biosci 179: 1-19.
20. Keeling M, Grenfell B (1997) Disease extinction and community size: modeling the persistence of measles. Science 275: 65-67.
21. Kirupaharan N, Allen L (2004) Coexistence of multiple pathogen strains in stochastic epidemic models with density-dependent mortality. Bull Mathem Biol 66: 841-864.
22. Restif O, Grenfell B (2006) Integrating life history and cross-immunity into the evolutionary dynamics of pathogens. Proc R Soc B 273: 409-416.
23. Webb S, Keeling M, Boots M (2007) Host-parasite interactions between the local and the mean-field: how and when does spatial population structure matter? J Theor Biol 249: 140-152.
24. Boots M, Mealor M (2007) Local interactions select for lower pathogen infectivity. Science 315: 1284-1286.
25. Mast E, Mahoney F, Kane M, Margolis H (2004) Hepatitis B vaccine. In: Plotkin S, Orenstein W, eds. Vaccines. Philadelphia: WB Saunders. pp 299-337. 4th ed.
26. Edmunds W, Medley G, Nokes D, Hall A, Whittle H (1993) The influence of age on the development of the hepatitis B carrier state. Proc R Soc Lond B 253: 197-201.
27. Zhao S, Xu Z, Lu Y (2000) A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in China. Intern J Epid 29: 744-752.
28. Edmunds W, Medley G, Nokes D (1996) The transmission dynamics and control of hepatitis B virus in The Gambia. Stat Med 15: 2215-2233.
29. WHO (2002) Hepatitis B. Available at: http://www.who.int/csr/disease/ hepatitis/ HepatitisB_whocdscsrlyo2002-2.pdf. Accessed 2008 June 4.
30. Williams J, Nokes D, Medley G, Anderson R (1996) The transmission dynamics of hepatitis B in the UK: a mathematical model for evaluating costs and effectiveness of immunization programmes. Epidemiol Infect 116: 71-89.
31. Hadler S, De Monzon M, Ponzetto A, Anzola E, Rivero D, et al. (1984) Delta virus infetion and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela. Ann Intern Med 100: 339-344.
32. van Houdt R, Sonder G, Dukers N, Bovee L, van den Hoek A, et al. (2007) Impact of a targeted hepatitis B vaccination program in Amsterdam, The Netherlands. Vaccine 25: 2698-2705.
33. Davidovich U, de Wit J, Stroebe W (2000) Assessing sexual risk behaviour of young gay men in primary relationships: the incorporation of negotiated safety and negotiated safety compliance. AIDS 14: 701-706.
34. Xiridou M, Wallinga J, Dukers-Muijers N, Coutinho R (2008) Hepatitis B vaccination and changes in sexual risk behaviour among men who have sex with men in Amsterdam. Epidemiol Infect. In press. Available online: doi:10.1017/S0950268808000976.